Unrecognized Tax Benefits of BIOCRYST PHARMACEUTICALS INC from 31 Dec 2012 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
BIOCRYST PHARMACEUTICALS INC quarterly Unrecognized Tax Benefits in USD history and change rate from 31 Dec 2012 to 31 Dec 2025.
  • BIOCRYST PHARMACEUTICALS INC Unrecognized Tax Benefits for the quarter ending 31 Dec 2025 was $14,498,000, a 1.5% decline year-over-year.
Source SEC data
View on sec.gov
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

BIOCRYST PHARMACEUTICALS INC Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $14,498,000 -$217,000 -1.5% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q4 2024 $14,715,000 +$353,000 +2.5% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q4 2023 $14,362,000 +$518,000 +3.7% 31 Dec 2023 10-K 26 Feb 2026 2025 FY
Q4 2022 $13,844,000 +$4,115,000 +42% 31 Dec 2022 10-K 25 Feb 2025 2024 FY
Q4 2021 $9,729,000 +$1,499,000 +18% 31 Dec 2021 10-K 27 Feb 2024 2023 FY
Q4 2020 $8,230,000 +$1,020,000 +14% 31 Dec 2020 10-K 27 Feb 2023 2022 FY
Q4 2019 $7,210,000 +$1,234,000 +21% 31 Dec 2019 10-K 28 Feb 2022 2021 FY
Q4 2018 $5,976,000 +$1,226,000 +26% 31 Dec 2018 10-K 01 Mar 2021 2020 FY
Q4 2017 $4,750,000 +$495,000 +12% 31 Dec 2017 10-K 13 Mar 2020 2019 FY
Q4 2016 $4,255,000 +$1,170,000 +38% 31 Dec 2016 10-K 14 Mar 2019 2018 FY
Q4 2015 $3,085,000 +$2,613,000 +554% 31 Dec 2015 10-K 12 Mar 2018 2017 FY
Q4 2014 $472,000 +$188,000 +66% 31 Dec 2014 10-K 27 Feb 2017 2016 FY
Q4 2013 $284,000 +$284,000 31 Dec 2013 10-K 26 Feb 2016 2015 FY
Q4 2012 $0 31 Dec 2012 10-K 11 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.